Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

The advent of tumor immunotherapy in patients has revolutionized the treatment of tumors and significantly improved survival rates for a wide range of tumors. However, the full therapeutic potential of immune checkpoint inhibitors (ICIs) has yet to be realized, as not all patients have a lasting survival benefit from them, and a significant proportion of patients show primary or acquired resistance to immunotherapy. Bifidobacterium is one of the most common probiotics, and its antitumor and immunomodulatory effects have been demonstrated in recent years, but its immunomodulatory effects in tumors, especially on ICIs and in combination, have not been extensively studied in clinical practice, and its effects on the immune system and the mechanisms that modulate immunotherapy are largely unknown. Therefore, this review will focus on the immunomodulatory effects of Bifidobacteria in malignancies and the possible mechanisms of action of Bifidobacteria on immunotherapy in the hope of providing a basis for further research and better application of Bifidobacteria in clinical practice. © 2024. The Author(s).

Citation

Bo Pei, Shixuan Peng, Chuying Huang, Fuxiang Zhou. Bifidobacterium modulation of tumor immunotherapy and its mechanism. Cancer immunology, immunotherapy : CII. 2024 Apr 02;73(5):94

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 38564002

View Full Text